Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Earl Silverman

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Immunology|May 19, 2023
Persistently active interferon-γ pathway and expansion of T-bet<sup>+</sup> B cells in a subset of patients with childhood-onset systemic lupus erythematosusGian Marco Moneta, Claudia Bracaglia, Ivan Caiello, et al.
Annals of the Rheumatic Diseases|October 27, 2012
Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO studyPaivi M Miettunen, Angela Pistorio, Elena Palmisani, et al.
Rheumatology (Oxford, England)|July 2, 2003
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositisNicolino Ruperto, Angelo Ravelli, Kevin J Murray, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
Arthritis and Rheumatism|September 30, 2008
Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trialSamantha Stephens, Brian M Feldman, Nicolette Bradley, et al.
Arthritis Care & Research|February 13, 2013
Association of smoking with cutaneous manifestations in systemic lupus erythematosusJosiane Bourré-Tessier, Christine A Peschken, Sasha Bernatsky, et al.
The Journal of Rheumatology|September 17, 2018
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus ErythematosusChristine A Peschken, Yishu Wang, Michal Abrahamowicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidaseChaim O Jacob, Miriam Eisenstein, Mary C Dinauer, et al.
Annals of the Rheumatic Diseases|May 20, 2014
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Immunology|May 19, 2023
Persistently active interferon-γ pathway and expansion of T-bet<sup>+</sup> B cells in a subset of patients with childhood-onset systemic lupus erythematosusGian Marco Moneta, Claudia Bracaglia, Ivan Caiello, et al.
Annals of the Rheumatic Diseases|October 27, 2012
Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO studyPaivi M Miettunen, Angela Pistorio, Elena Palmisani, et al.
Rheumatology (Oxford, England)|July 2, 2003
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositisNicolino Ruperto, Angelo Ravelli, Kevin J Murray, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
Arthritis and Rheumatism|September 30, 2008
Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trialSamantha Stephens, Brian M Feldman, Nicolette Bradley, et al.
Arthritis Care & Research|February 13, 2013
Association of smoking with cutaneous manifestations in systemic lupus erythematosusJosiane Bourré-Tessier, Christine A Peschken, Sasha Bernatsky, et al.
The Journal of Rheumatology|September 17, 2018
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus ErythematosusChristine A Peschken, Yishu Wang, Michal Abrahamowicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidaseChaim O Jacob, Miriam Eisenstein, Mary C Dinauer, et al.
Annals of the Rheumatic Diseases|May 20, 2014
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
Pageof 7